iCAD, Inc. (ICAD) - רווחיות מכירות לפי רווח נקי

Net profit margin reflects the automation dynamics of mammogram analysis via AI platforms. High computer vision accuracy in early pathology detection and the B2B integration of ProFound software into oncology centers ensure business stability. Meanwhile, the -26.80 level captures the latest sales margin figures, allowing for a real-time assessment of iCAD, Inc. (ICAD) efficiency relative to industry yield standards.
פילוחים אנליטיים ודוחות נתונים של חברת iCAD Inc. (ICAD)

Investors are attracted to the resilience of iCAD, Inc. (ICAD) against market volatility. Net margin measures the portion of profit remaining after all expenses are deducted from revenue, determining the efficiency of converting sales into capital. By analyzing the profit margin ratio, one can assess the business's ability to generate cash flow. Strong pricing power in the AI breast cancer diagnostics segment supports this metric. The fundamental growth of this metric confirms the uniqueness of the ProFound AI platform.